FDA Enforcement Class II Ongoing

iLet Bionic Pancreas, REF: BB1001

Recall: Z-2513-2026 · Reported June 24, 2026

Enforcement

Recall Number
Z-2513-2026
Event ID
98517
Classification
Class II
Status
Ongoing
Product Type
Devices
Firm
Beta Bionics, Inc.
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
June 24, 2026
Initiation Date
September 23, 2025
Classification Date
June 18, 2026
Address
11 Hughes, Irvine, CA, 92618-1902, United States

Description

iLet Bionic Pancreas, REF: BB1001

Reason

The reason for the recall is: it was found in version 3.3.6 of the iLet ACE Pump firmware and all previous releases that a screen unlock failure could occur when the user successfully slides the unlock slider on the Lock Screen, no screen transition occurs, and the user remains on the Lock Screen. Because the user cannot exit the Lock Screen, the user is unable to perform a cartridge change or meal announcement. If this occurs and therapy is in progress, therapy will continue normally until the insulin cartridge is depleted. The user will be unable to perform a cartridge change or a meal announcement and will be stuck on the screen until the battery fully drains. This can lead to hyperglycemia.

Code Info

iLet ACE Pump firmware BOM000072 Rev C (version 3.3.6) and BOM000072 Rev B (version 3.3.4)

Distribution

US: WI, HI, OH, ME, CO, NJ, NE, KY, SC, CA, TX, NH, NY, WA, PA, MD, FL, IA, GA, MI, VT, TN, IL, IN, KS, MA, LA, MS, NC, CT, MN, VA, OK, AR, AZ, MO, MT, RI, DC, NM, OR, ID, NV, AK, ND, DE, WV, WY, SD, UT, AL

Quantity

4580